Lieke Maas

Publication Activity (10 Years)

Years Active: 2023-2024
Publications (10 Years): 13

Top Topics

Health Insurance

Prognostic Factors

Bone Mineral Density

Top Venues

Therapeutic innovation & regulatory science

Archives of osteoporosis

Expert review of pharmacoeconomics & outcomes research

Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA

This page only lists publications with an associated author ORCID identifier.

Publications

Lieke Maas, Angelika Joos, Mickaël J C Hiligsmann
Pediatric Market Access: A Qualitative Study. Therapeutic innovation & regulatory science 58 (2) (2024)
Lieke Maas, Annelies Boonen, Caroline E Wyers, Sandrine Bours, Joop P W van den Bergh, Silvia M A A Evers, Justin G L M Luermans, Mickaël J C Hiligsmann
Societal costs before and up to 1 year after the first fracture liaison service visit in patients requiring anti-osteoporosis treatments. Archives of osteoporosis 19 (1) (2024)
Lieke Maas, Angelika Joos, Mickaël J C Hiligsmann
Pediatric Market Access: A Qualitative Study. Therapeutic innovation & regulatory science 58 (2) (2024)
Lieke Maas, Angelika Joos, Mickaël J C Hiligsmann
Pediatric Market Access: A Qualitative Study. Therapeutic innovation & regulatory science 58 (2) (2024)
Lieke Maas, Annelies Boonen, Nannan Li, Caroline E Wyers, Joop P W van den Bergh, Mickaël J C Hiligsmann
Cost-effectiveness of a multicomponent-adherence intervention in fracture liaison services. Expert review of pharmacoeconomics & outcomes research (2024)
Lieke Maas, Annelies Boonen, Nannan Li, Caroline E Wyers, Joop P W van den Bergh, Mickaël J C Hiligsmann
Cost-effectiveness of a multicomponent-adherence intervention in fracture liaison services. Expert review of pharmacoeconomics & outcomes research (2024)
Lieke Maas, Angelika Joos, Mickaël J C Hiligsmann
Pediatric Market Access: A Qualitative Study. Therapeutic innovation & regulatory science (2024)
Lieke Maas, Annelies Boonen, Caroline E Wyers, Sandrine Bours, Joop P W van den Bergh, Silvia M A A Evers, Justin G L M Luermans, Mickaël J C Hiligsmann
Societal costs before and up to 1 year after the first fracture liaison service visit in patients requiring anti-osteoporosis treatments. Archives of osteoporosis 19 (1) (2024)
Lieke Maas, Angelika Joos, Mickaël J C Hiligsmann
Pediatric Market Access: A Qualitative Study. Therapeutic innovation & regulatory science 58 (2) (2024)
Lieke Maas, Annelies Boonen, Caroline E Wyers, Sandrine Bours, Joop P W van den Bergh, Silvia M A A Evers, Justin G L M Luermans, Mickaël J C Hiligsmann
Societal costs before and up to 1 year after the first fracture liaison service visit in patients requiring anti-osteoporosis treatments. Archives of osteoporosis 19 (1) (2024)
Lieke Maas, Angelika Joos, Mickaël J C Hiligsmann
Pediatric Market Access: A Qualitative Study. Therapeutic innovation & regulatory science 58 (2) (2024)
Lieke Maas, Angelika Joos, Mickaël J C Hiligsmann
Pediatric Market Access: A Qualitative Study. Therapeutic innovation & regulatory science 58 (2) (2024)
Lieke Maas, Nele Raskin, Marloes van Onna, Dennis Cornelissen, Sandrine Bours, Trudy van der Weijden, Joop P W van den Bergh, Marsha M van Oostwaard, Caroline E Wyers, Mickaël J C Hiligsmann, Annelies Boonen
Development and usability of a decision aid to initiate anti-osteoporosis medication treatment in patients visiting the fracture liaison service with a recent fracture. Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA (2023)